BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 180 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,943,000 | +260.9% | 226,782 | +486.7% | 0.35% | +328.0% |
| Q4 2021 | $4,140,000 | -75.6% | 38,654 | -76.6% | 0.08% | -68.3% |
| Q3 2021 | $16,971,000 | -0.6% | 165,069 | -15.0% | 0.26% | +7.0% |
| Q2 2021 | $17,080,000 | +50.3% | 194,183 | +66.1% | 0.24% | +69.2% |
| Q1 2021 | $11,367,000 | -50.7% | 116,911 | -43.1% | 0.14% | -43.5% |
| Q4 2020 | $23,042,000 | +107.7% | 205,454 | +71.7% | 0.25% | +19.3% |
| Q3 2020 | $11,092,000 | +468.8% | 119,652 | +378.6% | 0.21% | +307.7% |
| Q2 2020 | $1,950,000 | -26.1% | 25,000 | -28.6% | 0.05% | +8.3% |
| Q4 2017 | $2,639,000 | – | 35,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |